Evidence map›Paper›PMID 27313305›Full record

ArticleGenome announcements2016

Whole-Genome Sequencing of a Haarlem Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolate from Medellín, Colombia.

N Alvarez, D Haft, U A Hurtado, J Robledo, F Rouzaud

Abstract read
In one paragraph

Article in Genome announcements, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

N AlvarezCorporación para Investigaciones Biológicas-CIB, Medellín, Colombia Universidad Pontificia Bolivariana-UPB, Medellín, Colombia nalvarez@cib.org.co.
D HaftJ. Craig Venter Institute, Rockville, Maryland, USA.
U A HurtadoCorporación para Investigaciones Biológicas-CIB, Medellín, Colombia.
J RobledoCorporación para Investigaciones Biológicas-CIB, Medellín, Colombia Universidad Pontificia Bolivariana-UPB, Medellín, Colombia.
F RouzaudCorporación para Investigaciones Biológicas-CIB, Medellín, Colombia Equal Opportunity Life Sciences-EQUOLS, Rockville, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colombia is one of the 105 countries that has reported at least one case of extensively drug-resistant tuberculosis (XDR-TB). The Mycobacterium tuberculosis Haarlem genotype is ubiquitous worldwide. Here, we report the high-quality draft genome sequence of a Colombian Haarlem XDR-TB clinical isolate composed of 4,329,127 bp with 4,386 genes.

Identifiers

PMID27313305
PMCPMC4911484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.